Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
39°
Light Rain
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Phathom Pharmaceuticals, Inc. - Common Stock
(NQ:
PHAT
)
4.305
-0.085 (-1.94%)
Streaming Delayed Price
Updated: 11:47 AM EDT, May 20, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Phathom Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
Next >
9 Health Care Stocks With Whale Alerts In Today's Session
May 16, 2025
Via
Benzinga
Top movers in Friday's session
May 09, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Keep an eye on the top gainers and losers in Friday's session.
May 09, 2025
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Earnings Scheduled For May 1, 2025
May 01, 2025
Via
Benzinga
Preview: Phathom Pharmaceuticals's Earnings
March 06, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
May 09, 2025
Via
Benzinga
Retail Interest in Phathom Soars As Firm Pledges Profit Path, Cuts Costs After Q1 Miss
May 02, 2025
Phathom's VOQUEZNA prescriptions rose 8% sequentially in Q1, with over 390,000 cumulative fills and expanding adoption across both GI and primary care.
Via
Stocktwits
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Here are the top movers in Thursday's session.
May 01, 2025
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Top stock movements in today's session.
May 01, 2025
Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
May 01, 2025
Via
Benzinga
The market is filled with gapping stocks in Thursday's session.
May 01, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
Via
Chartmill
Insights Ahead: Phathom Pharmaceuticals's Quarterly Earnings
April 30, 2025
Via
Benzinga
Top movers in Tuesday's session
April 01, 2025
Stay up-to-date with the latest market trends one hour before the close of the markets on Tuesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
Traders are paying attention to the gapping stocks in Tuesday's session.
March 18, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
IHS Holding Posts Upbeat Earnings, Joins Tencent Music Entertainment, Elbit Systems And Other Big Stocks Moving Higher On Tuesday
March 18, 2025
Via
Benzinga
Top Biotech Short Squeeze Stocks
December 12, 2024
Investing in biotechnology stocks offers a unique opportunity for individuals looking to gain exposure to one of the most dynamic and innovative sectors of the market.
Via
Talk Markets
Topics
Stocks / Equities
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via
Benzinga
Earnings Scheduled For March 6, 2025
March 06, 2025
Via
Benzinga
These Are The Top 3 Most-Shorted Stocks In August 2024; Here’s Why
August 21, 2024
Short-squeeze opportunities are tough to find. Combine market timing with fundamentals for these stocks.
Via
Talk Markets
PHAT Stock Earnings: Phathom Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
PHAT stock results show that Phathom Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Ready for Quick Gains? 7 Top Short-Squeeze Stocks to Watch Now
June 09, 2024
Each of the following seven heavily-shorted stocks may have what it takes to become one of the next big short squeeze stocks.
Via
InvestorPlace
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
June 07, 2024
Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right.
Via
InvestorPlace
The 3 Best Healthcare Stocks to Buy in May 2024
May 10, 2024
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.
Via
InvestorPlace
PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
March 07, 2024
PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
February 20, 2024
U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
February 19, 2024
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 16, 2024
Via
Benzinga
"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales
January 05, 2024
Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.